Detail akcie AddLife Rg-B online

Business Summary: AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, AddLife AB revenues increased 2% to SEK10.44B. Net income increased from SEK252M to SEK560M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest Exp-Net of Capitalized Interest decrease of 28% to SEK202M (expense), Financial income and expenses - Bal decrease of 64% to SEK9M (expense).